APA (7th ed.) Citation

AY, A., MA, E., N, F., MA, A., MM, M., O, E., . . . DJ, A. (2025). Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study. Endocrinology, diabetes & metabolism, 8(2), e70019. https://doi.org/10.1002/edm2.70019

Chicago Style (17th ed.) Citation

AY, Azzam, et al. "Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study." Endocrinology, Diabetes & Metabolism 8, no. 2 (2025): e70019. https://doi.org/10.1002/edm2.70019.

MLA (9th ed.) Citation

AY, Azzam, et al. "Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study." Endocrinology, Diabetes & Metabolism, vol. 8, no. 2, 2025, p. e70019, https://doi.org/10.1002/edm2.70019.